AXISCADES Technologies Ltd
AXISCADES Technologies Ltd Q2 FY26 Results & Concall Highlights: Capex ₹450 Cr
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
AXISCADES targets over 40% annual growth in core businesses (aerospace, defense, ESAI) for FY26 and FY27, with further acceleration as new facilities become operational. AXISCADES targets over 40% year-on-year growth in core businesses for FY26 and FY27, with acceleration to over 70% growth projected for FY28-30 as new facilities come online (Page 4, Page 5).
From AXISCADES Technologies Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- AXISCADES targets over 40% annual growth in core businesses (aerospace, defense, ESAI) for FY26 and FY27, with further acceleration as new facilities become operational.
- Confident to achieve FY26 guidance in revenue and profitability, supported by a strong order book and strategic alliances.
- Defense revenues grew 37% YoY in Q2 and 31% in H1; aerospace grew 16% in Q2 and 12% in H1.
- Mistral EMS facility coming online by March 2026 expected to generate $8-10 million revenue in FY27.
- Anticipated growth from hyperscaler clients, expecting to scale from $2 million this year to $6-7 million next year if facilities are ready.
- Robust outlook for LLTR order by January 2026; QRSAM segment revenue expected mainly from FY27 onwards.
- Aim to reach $1 billion (Rs. 9,000 crores) revenue by 2030, driven by phased CAPEX and facility expansion.
- Continued focus on converting 60% of pipeline into confirmed orders with strong visibility through 2028-2030.
Profitability & Margins
See what AXISCADES Technologies Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- AXISCADES plans phased capital investment totaling approximately Rs.1,500 crores over three years, including Hyderabad facility.
- Phase-I CAPEX is around Rs.150-180 crores for FY26, for Bangalore facility and related infrastructure.
- Phase-II CAPEX will be about Rs.450 crores, with remaining CAPEX in Phase-III.
- Funds expected from divestment of non-core assets, internal accruals, and strategic investments from foreign OEMs.
- Management aims to minimize debt, with any borrowing likely limited to bridge financing not exceeding Rs.50 crores in FY26.
- Strategic investment discussions are ongoing, possibly to occur in Q1 FY27, likely through an SPV holding facility land; no equity dilution planned in the listed entity currently.
- Missile Atmanirbhar Complex in Hyderabad and Devanahalli Atmanirbhar Complex ongoing with additional investment plans.
Top-ranked in Aerospace & Defense
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what AXISCADES Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Pipeline orders: Approximately Rs.12,000 crores were expected to convert into confirmed orders; conversion is ongoing and being actively worked on (Page 16).
- QRSAM segment: Expecting around seven systems in the next two months, with production orders anticipated by March 2026, contributing revenue from FY27 (Page 17).
- LLTR order: Awaiting negotiation with Bharat Electronics, expected order by January (Page 19).
- Defense segment: Strong visibility for FY27, FY28, FY29, and FY30 with comfortable order book and growth trajectory (Page 17).
- Emergency procurement orders for man-portable counter-drone systems already received; more trials ongoing (Page 12).
- MBDA test benches: Supply ongoing with plans to deliver around 10 benches per year (Page 13).
- BrahMos seeker: Trials expected to complete by March, with orders potentially starting next year (Page 13).
AXISCADES Technologies Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹273 Cr, net profit ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What AXISCADES Tech.'s management said in earlier quarters
Others in Aerospace & Defense this season
- Unimech Aerospace and Manufacturing Ltd (Q2 FY26)
1,000 crores in revenue by FY29, with approximately 65% from aero tooling and 35% from nuclear and precision segments. Key concall takeaways from Unimech…
- Techera Engineering India Ltd (Q2 FY26)
They are working closely with Jeh Aerospace and have received multiple orders adding around ₹5-7 crore every quarter. Key concall takeaways from Techera…
- Cyient DLM Ltd (Q2 FY26)
Current order book stands at approximately INR 2,300 crores. Key concall takeaways from Cyient DLM Ltd's Q2 FY26 earnings call — and how it ranks against…
- Zen Technologies Ltd (Q2 FY26)
Quarterly order book scaling from Rs.250-300 Crores to Rs.500-750 Crores is planned, with execution capacity scaling accordingly. Key concall takeaways from…
Frequently Asked Questions
What were AXISCADES Technologies Ltd Q2 FY26 results?
AXISCADES targets over 40% annual growth in core businesses (aerospace, defense, ESAI) for FY26 and FY27, with further acceleration as new facilities become operational. AXISCADES targets over 40% year-on-year growth in core businesses for FY26 and FY27, with acceleration to over 70% growth projected for FY28-30 as new facilities come online (Page 4, Page 5).
What is AXISCADES Technologies Ltd share price analysis?
AXISCADES Technologies Ltd currently shows a neutral. The stock trades at a P/E of 85.6 with a market cap of ₹6,764 Cr. Investors should review the full earnings analysis for detailed insights.
Is AXISCADES Technologies Ltd planning capital expenditure?
AXISCADES plans phased capital investment totaling approximately Rs.1,500 crores over three years, including Hyderabad facility.
Keep AXISCADES Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.